EPA:EL • FR0000121667
The current stock price of EL.PA is 258.3 EUR. In the past month the price decreased by -4.69%. In the past year, price decreased by -12.29%.
ChartMill assigns a technical rating of 1 / 10 to EL.PA. When comparing the yearly performance of all stocks, EL.PA is a bad performer in the overall market: 87.78% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to EL.PA. While EL.PA is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months EL.PA reported a non-GAAP Earnings per Share(EPS) of 6.87. The EPS increased by 3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.74% | ||
| ROA | 3.84% | ||
| ROE | 6.29% | ||
| Debt/Equity | 0.25 |
31 analysts have analysed EL.PA and the average price target is 337.51 EUR. This implies a price increase of 30.67% is expected in the next year compared to the current price of 258.3.
For the next year, analysts expect an EPS growth of 5.69% and a revenue growth 5.99% for EL.PA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ESL | ESSILORLUXOTTICA | 32.33 | 121.114B | ||
| 1EL | ESSILORLUXOTTICA | 32.14 | 120.558B | ||
| GBT | GUERBET | 98.44 | 177.213M | ||
| AFME | CARVOLIX SA | N/A | 110.574M | ||
| ALCJ | CROSSJECT | 5.93 | 106.737M | ||
| SVS | SVAS BIOSANA SPA | 5.78 | 47.712M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 47.12M | ||
| IVN | IVISION TECH SPA | N/A | 15.029M | ||
| CVX | CARVOLIX SA | N/A |
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
EssilorLuxottica SA engages in the design, manufacture, and distribution of ophthalmic lenses, frames and sunglasses. The company is headquartered in Paris, Ile-De-France and currently employs 200,076 full-time employees. The firm designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. The company also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. The company operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.
ESSILORLUXOTTICA
1-6 rue Paul Cezanne
Paris ILE-DE-FRANCE FR
Employees: 153498
Phone: 33149774224
EssilorLuxottica SA engages in the design, manufacture, and distribution of ophthalmic lenses, frames and sunglasses. The company is headquartered in Paris, Ile-De-France and currently employs 200,076 full-time employees. The firm designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. The company also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. The company operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.
The current stock price of EL.PA is 258.3 EUR. The price decreased by -1.15% in the last trading session.
ESSILORLUXOTTICA (EL.PA) has a dividend yield of 1.53%. The yearly dividend amount is currently 2.56.
EL.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EL.PA.
ESSILORLUXOTTICA (EL.PA) has a market capitalization of 119.67B EUR. This makes EL.PA a Large Cap stock.
You can find the ownership structure of ESSILORLUXOTTICA (EL.PA) on the Ownership tab.